Kewaunee Scientific Corporation Common Stock (KEQU)

FairStock Score: 60/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for small, understandable businesses selling below intrinsic value with a margin of safety. Kewaunee fits the first part: it designs and installs laboratory, healthcare, and technical furniture, a niche industrial business. At the 2026-10-13 close of $32.20, FairStock calculates a P/E of 11.67, P/B of 1.24, and a Graham Number of $40.11, leaving about a 19.72% margin of safety. TTM free cash flow is $10.9M, an 11.7% FCF yield, and EV/EBITDA is 5.15 — cheap-looking. But quality is uneven. ROE is 12.53%, while ROCE is only 5.10%, suggesting limited returns on total capital. Debt/equity is 0.72, Altman Z is 1.95, and Piotroski is 5/9, not a fortress. Growth has soured: in fiscal Q1 2027, the quarter ended 2026-07-31, revenue was $66.3M, net income $1.7M, and diluted EPS $0.58, versus fiscal Q1 2026, the quarter ended 2025-07-31, revenue of $71.1M, net income of $3.1M, and diluted EPS of $1.04. In fiscal 2026, the year ended 2026-04-30, revenue rose to $282.0M from $240.5M in fiscal 2025, the year ended 2025-04-30, but net income fell to $9.6M from $11.4M, and diluted EPS fell to $3.22 from $3.83. FairStock classifies it as a STALWART, with three-year profit growth of 135.3% a year and revenue growth of 8.7%, but the latest filings show contraction. I would want stabilization in margins and cash generation before treating the discount as durable.

In plain English: Kewaunee Scientific makes and installs lab, healthcare, and technical furniture. The business is still profitable and produces cash, but sales and profits have recently fallen and it uses some debt. The stock price looks low compared with the company's earnings and cash flow, though the weak recent trend means it is not a clear bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2027 10-Q (period ended 2026-07-31) · fiscal Q3 2026 10-Q (period ended 2026-01-31) · fiscal Q2 2026 10-Q (period ended 2025-10-31) · fiscal Q1 2026 10-Q (period ended 2025-07-31) · FY2026 10-K (period ended 2026-04-30) · FY2025 10-K (period ended 2025-04-30) · FY2024 10-K (period ended 2024-04-30)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer